Cellcolabs Clinical Spv Limited

This early-phase study tested whether a single injection of donor bone-marrow stem cells (StromaForte) is safe for people with mild-to-moderate knee osteoarthritis. Twelve adults received the injection and were monitored for side effects over 24 weeks. The main goal was safety, n…

This early-phase trial tested the safety of StromaForte, a stem cell product made from donor bone marrow, in 12 frail adults aged 60 to 85. Participants received a single intravenous infusion of 100 million cells. The main goal was to check for side effects within 28 days, with f…